labetalol and indacaterol

labetalol has been researched along with indacaterol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, X; Hu, B; Li, C; Ma, Y; Wang, J; Wang, Y; Xue, W; Zhang, F; Zhang, T1

Other Studies

1 other study(ies) available for labetalol and indacaterol

ArticleYear
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification.
    European journal of medicinal chemistry, 2020, May-01, Volume: 193

    Topics: A549 Cells; Carvedilol; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP1B1; Density Functional Theory; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured

2020